Neurogene Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Neurogene Inc. (NGNE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 859.87 thousand shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2023-11-14
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-09-30 was -3.28M shares, a 751.46% decline year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-06-30 was 836.04K shares, a 18.33% decline year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-03-31 was 3.30M shares, a 145.52% increase year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-12-31 was 972.12K shares, a 0.90% decline year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 3.84M shares, a 248.37% increase from fiscal 2021.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 1.10M shares, a 113.88% increase from fiscal 2020.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 515.92K shares, a 30.95% decline from fiscal 2019.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 747.16K shares, a 35.76% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2023-09-30 | -3.28M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -2.44M shares derived: sum of 2 quarters · filed 2023-11-14 | 859.87K shares 10-Q · filed 2023-11-14 | 1.83M shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | 836.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 4.14M shares 10-Q · filed 2023-08-10 | 5.11M shares derived: sum of 3 quarters · filed 2023-08-10 | 5.61M shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 3.30M shares 10-Q · filed 2023-05-08 | 4.27M shares derived: sum of 2 quarters · filed 2023-05-08 | 4.78M shares derived: sum of 3 quarters · filed 2023-05-08 | 5.80M shares derived: sum of 4 quarters · filed 2023-05-08 |
| 2022-12-31 | 972.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 1.48M shares derived: sum of 2 quarters · filed 2023-03-20 | 2.50M shares derived: sum of 3 quarters · filed 2023-03-20 | 3.84M shares 10-K · filed 2023-03-20 |
| 2022-09-30 | 503.24K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 1.53M shares derived: sum of 2 quarters · filed 2022-11-14 | 2.87M shares 10-Q · filed 2022-11-14 | 3.85M shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 1.02M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 2.37M shares 10-Q · filed 2022-08-09 | 3.35M shares derived: sum of 3 quarters · filed 2022-08-09 | 3.40M shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 1.35M shares 10-Q · filed 2022-05-09 | 2.33M shares derived: sum of 2 quarters · filed 2022-05-09 | 2.38M shares derived: sum of 3 quarters · filed 2022-05-09 | 2.44M shares derived: sum of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 980.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 1.03M shares derived: sum of 2 quarters · filed 2022-03-01 | 1.10M shares derived: sum of 3 quarters · filed 2022-03-01 | 1.10M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 49.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 118.76K shares derived: sum of 2 quarters · filed 2021-11-04 | 122.53K shares 10-Q · filed 2021-11-04 | 141.12K shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 69.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 73.38K shares 10-Q · filed 2021-08-05 | 91.96K shares derived: sum of 3 quarters · filed 2021-08-05 | 125.59K shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 3.77K shares 10-Q · filed 2021-05-12 | 22.36K shares derived: sum of 2 quarters · filed 2021-05-12 | 55.99K shares derived: sum of 3 quarters · filed 2021-05-12 | 109.70K shares derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-12-31 | 18.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 52.22K shares derived: sum of 2 quarters · filed 2021-03-25 | 105.92K shares derived: sum of 3 quarters · filed 2021-03-25 | 515.92K shares 10-K · filed 2021-03-25 |
| 2020-09-30 | 33.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 87.34K shares derived: sum of 2 quarters · filed 2020-11-09 | 497.34K shares 10-Q · filed 2020-11-09 | 966.30K shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 53.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | 463.71K shares 10-Q · filed 2020-08-12 | 932.67K shares derived: sum of 3 quarters · filed 2020-08-12 | 944.67K shares derived: sum of 4 quarters · filed 2020-08-12 |
| 2020-03-31 | 410.00K shares 10-Q · filed 2020-05-06 | 878.97K shares derived: sum of 2 quarters · filed 2020-05-06 | 890.97K shares derived: sum of 3 quarters · filed 2020-05-06 | 893.07K shares derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-12-31 | 468.96K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 480.96K shares derived: sum of 2 quarters · filed 2020-03-12 | 483.06K shares derived: sum of 3 quarters · filed 2020-03-12 | 747.16K shares 10-K · filed 2020-03-12 |
| 2019-09-30 | 12.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | 14.10K shares derived: sum of 2 quarters · filed 2019-11-13 | 278.20K shares 10-Q · filed 2019-11-13 | 740.27K shares derived: sum of 4 quarters · filed 2019-11-13 |
| 2019-06-30 | 2.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 266.20K shares 10-Q · filed 2019-08-01 | 728.27K shares derived: sum of 3 quarters · filed 2019-08-01 | 1.21M shares derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-31 | 264.10K shares 10-Q · filed 2019-05-07 | 726.17K shares derived: sum of 2 quarters · filed 2019-05-07 | 1.20M shares derived: sum of 3 quarters · filed 2019-05-07 | 1.37M shares derived: sum of 4 quarters · filed 2019-05-07 |
| 2018-12-31 | 462.07K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 939.60K shares derived: sum of 2 quarters · filed 2019-03-07 | 1.10M shares derived: sum of 3 quarters · filed 2019-03-07 | 1.16M shares 10-K · filed 2019-03-07 |
| 2018-09-30 | 477.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 640.14K shares derived: sum of 2 quarters · filed 2018-11-07 | 700.99K shares 10-Q · filed 2018-11-07 | 738.61K shares derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | 162.61K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 223.46K shares 10-Q · filed 2018-08-08 | 261.08K shares derived: sum of 3 quarters · filed 2018-08-08 | 261.84K shares derived: sum of 4 quarters · filed 2018-08-08 |
| 2018-03-31 | 60.85K shares 10-Q · filed 2018-05-08 | 98.47K shares derived: sum of 2 quarters · filed 2018-05-08 | 99.23K shares derived: sum of 3 quarters · filed 2018-05-08 | 99.23K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | 37.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 38.38K shares derived: sum of 2 quarters · filed 2018-03-12 | 38.38K shares derived: sum of 3 quarters · filed 2018-03-12 | 97.44K shares 10-K · filed 2018-03-12 |
| 2017-09-30 | 757.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 757.00 shares derived: sum of 2 quarters · filed 2017-11-08 | 59.82K shares 10-Q · filed 2017-11-08 | 59.82K shares derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 59.06K shares 10-Q · filed 2017-08-08 | 59.06K shares derived: sum of 3 quarters · filed 2017-08-08 | 59.06K shares derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | 59.06K shares 10-Q · filed 2017-05-09 | 59.06K shares derived: sum of 2 quarters · filed 2017-05-09 | 59.06K shares derived: sum of 3 quarters · filed 2017-05-09 | 134.36K shares derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | 0.00 shares derived: sum of 2 quarters · filed 2017-03-09 | 75.30K shares derived: sum of 3 quarters · filed 2017-03-09 | 82.14K shares 10-K · filed 2017-03-09 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 75.30K shares derived: sum of 2 quarters · filed 2016-11-09 | 82.14K shares 10-Q · filed 2016-11-09 | 82.14K shares derived: sum of 4 quarters · filed 2016-11-09 |
| 2016-06-30 | 75.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 82.14K shares 10-Q · filed 2016-08-04 | 82.14K shares derived: sum of 3 quarters · filed 2016-08-04 | 131.49K shares derived: sum of 4 quarters · filed 2016-08-04 |
| 2016-03-31 | 6.84K shares 10-Q · filed 2016-05-10 | 6.84K shares derived: sum of 2 quarters · filed 2016-05-10 | 56.19K shares derived: sum of 3 quarters · filed 2016-05-10 | 56.19K shares derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 49.35K shares derived: sum of 2 quarters · filed 2016-03-14 | 49.35K shares derived: sum of 3 quarters · filed 2016-03-14 | 49.35K shares 10-K · filed 2016-03-14 |
| 2015-09-30 | 49.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | 49.35K shares derived: sum of 2 quarters · filed 2015-11-10 | 49.35K shares 10-Q · filed 2015-11-10 | |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 0.00 shares 10-Q · filed 2015-08-06 | ||
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |